nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CNR2—osteoporosis	0.598	1	CbGaD
Rimonabant—CYP1A2—Estropipate—osteoporosis	0.0371	0.144	CbGbCtD
Rimonabant—CYP2C9—Estropipate—osteoporosis	0.0335	0.13	CbGbCtD
Rimonabant—CYP3A4—Estropipate—osteoporosis	0.0195	0.0755	CbGbCtD
Rimonabant—CYP3A4—Calcitriol—osteoporosis	0.0195	0.0755	CbGbCtD
Rimonabant—CYP1A2—Conjugated Estrogens—osteoporosis	0.0176	0.0681	CbGbCtD
Rimonabant—CYP2C9—Cholecalciferol—osteoporosis	0.0172	0.0669	CbGbCtD
Rimonabant—CYP2D6—Cholecalciferol—osteoporosis	0.0158	0.0612	CbGbCtD
Rimonabant—CYP3A4—Ergocalciferol—osteoporosis	0.0156	0.0603	CbGbCtD
Rimonabant—CYP1A2—Estradiol—osteoporosis	0.0154	0.0598	CbGbCtD
Rimonabant—CYP2C9—Estradiol—osteoporosis	0.0139	0.0539	CbGbCtD
Rimonabant—CYP3A4—Raloxifene—osteoporosis	0.013	0.0504	CbGbCtD
Rimonabant—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0125	0.0486	CbGbCtD
Rimonabant—CYP3A4—Cholecalciferol—osteoporosis	0.01	0.0389	CbGbCtD
Rimonabant—CYP3A4—Conjugated Estrogens—osteoporosis	0.0092	0.0357	CbGbCtD
Rimonabant—CYP3A4—Estradiol—osteoporosis	0.00808	0.0313	CbGbCtD
Rimonabant—Skin disorder—Raloxifene—osteoporosis	0.000251	0.00217	CcSEcCtD
Rimonabant—Nervous system disorder—Ibandronate—osteoporosis	0.00025	0.00216	CcSEcCtD
Rimonabant—Hyperhidrosis—Raloxifene—osteoporosis	0.000249	0.00216	CcSEcCtD
Rimonabant—Skin disorder—Ibandronate—osteoporosis	0.000248	0.00214	CcSEcCtD
Rimonabant—Muscle spasms—Risedronate—osteoporosis	0.000248	0.00214	CcSEcCtD
Rimonabant—Influenza—Estradiol—osteoporosis	0.000248	0.00214	CcSEcCtD
Rimonabant—Hyperhidrosis—Ibandronate—osteoporosis	0.000247	0.00213	CcSEcCtD
Rimonabant—Hypoaesthesia—Conjugated Estrogens—osteoporosis	0.000246	0.00213	CcSEcCtD
Rimonabant—Nausea—Ergocalciferol—osteoporosis	0.000246	0.00213	CcSEcCtD
Rimonabant—Malnutrition—Pamidronate—osteoporosis	0.000245	0.00212	CcSEcCtD
Rimonabant—Abdominal pain—Etidronic acid—osteoporosis	0.000243	0.0021	CcSEcCtD
Rimonabant—Skin disorder—Calcitriol—osteoporosis	0.000243	0.0021	CcSEcCtD
Rimonabant—Insomnia—Estropipate—osteoporosis	0.000241	0.00208	CcSEcCtD
Rimonabant—Tension—Pamidronate—osteoporosis	0.000241	0.00208	CcSEcCtD
Rimonabant—Paraesthesia—Estropipate—osteoporosis	0.000239	0.00207	CcSEcCtD
Rimonabant—Anorexia—Calcitriol—osteoporosis	0.000238	0.00206	CcSEcCtD
Rimonabant—Nervousness—Pamidronate—osteoporosis	0.000238	0.00206	CcSEcCtD
Rimonabant—Abdominal discomfort—Estradiol—osteoporosis	0.000237	0.00205	CcSEcCtD
Rimonabant—Muscle spasms—Pamidronate—osteoporosis	0.000236	0.00204	CcSEcCtD
Rimonabant—Angiopathy—Zoledronate—osteoporosis	0.000233	0.00202	CcSEcCtD
Rimonabant—Insomnia—Raloxifene—osteoporosis	0.000233	0.00202	CcSEcCtD
Rimonabant—Mediastinal disorder—Zoledronate—osteoporosis	0.000232	0.002	CcSEcCtD
Rimonabant—Insomnia—Ibandronate—osteoporosis	0.000231	0.002	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Estradiol—osteoporosis	0.00023	0.00199	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Estropipate—osteoporosis	0.00023	0.00199	CcSEcCtD
Rimonabant—Fatigue—Estropipate—osteoporosis	0.00023	0.00198	CcSEcCtD
Rimonabant—Paraesthesia—Ibandronate—osteoporosis	0.000229	0.00198	CcSEcCtD
Rimonabant—Insomnia—Calcitriol—osteoporosis	0.000226	0.00195	CcSEcCtD
Rimonabant—Mental disorder—Zoledronate—osteoporosis	0.000225	0.00195	CcSEcCtD
Rimonabant—Angiopathy—Conjugated Estrogens—osteoporosis	0.000225	0.00194	CcSEcCtD
Rimonabant—Anxiety—Ethinyl Estradiol—osteoporosis	0.000224	0.00194	CcSEcCtD
Rimonabant—Malnutrition—Zoledronate—osteoporosis	0.000224	0.00194	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000224	0.00193	CcSEcCtD
Rimonabant—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000223	0.00193	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000223	0.00192	CcSEcCtD
Rimonabant—Decreased appetite—Ibandronate—osteoporosis	0.000222	0.00192	CcSEcCtD
Rimonabant—Infestation NOS—Estradiol—osteoporosis	0.000221	0.00191	CcSEcCtD
Rimonabant—Infestation—Estradiol—osteoporosis	0.000221	0.00191	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000221	0.00191	CcSEcCtD
Rimonabant—Depression—Estradiol—osteoporosis	0.00022	0.0019	CcSEcCtD
Rimonabant—Fatigue—Ibandronate—osteoporosis	0.00022	0.0019	CcSEcCtD
Rimonabant—Anxiety—Risedronate—osteoporosis	0.000219	0.00189	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000218	0.00188	CcSEcCtD
Rimonabant—Pruritus—Etidronic acid—osteoporosis	0.000218	0.00188	CcSEcCtD
Rimonabant—Gastrointestinal pain—Estropipate—osteoporosis	0.000218	0.00188	CcSEcCtD
Rimonabant—Decreased appetite—Calcitriol—osteoporosis	0.000217	0.00188	CcSEcCtD
Rimonabant—Mental disorder—Conjugated Estrogens—osteoporosis	0.000217	0.00188	CcSEcCtD
Rimonabant—Malnutrition—Conjugated Estrogens—osteoporosis	0.000216	0.00186	CcSEcCtD
Rimonabant—Muscle spasms—Zoledronate—osteoporosis	0.000215	0.00186	CcSEcCtD
Rimonabant—Dry mouth—Risedronate—osteoporosis	0.000215	0.00186	CcSEcCtD
Rimonabant—Gastrointestinal pain—Alendronate—osteoporosis	0.000215	0.00185	CcSEcCtD
Rimonabant—Infection—Ethinyl Estradiol—osteoporosis	0.000214	0.00185	CcSEcCtD
Rimonabant—Convulsion—Pamidronate—osteoporosis	0.000212	0.00184	CcSEcCtD
Rimonabant—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000212	0.00183	CcSEcCtD
Rimonabant—Tension—Conjugated Estrogens—osteoporosis	0.000212	0.00183	CcSEcCtD
Rimonabant—Gastrointestinal pain—Raloxifene—osteoporosis	0.000211	0.00182	CcSEcCtD
Rimonabant—Diarrhoea—Etidronic acid—osteoporosis	0.000211	0.00182	CcSEcCtD
Rimonabant—Abdominal pain—Estropipate—osteoporosis	0.000211	0.00182	CcSEcCtD
Rimonabant—Tremor—Zoledronate—osteoporosis	0.00021	0.00181	CcSEcCtD
Rimonabant—Skin disorder—Ethinyl Estradiol—osteoporosis	0.00021	0.00181	CcSEcCtD
Rimonabant—Nervousness—Conjugated Estrogens—osteoporosis	0.000209	0.00181	CcSEcCtD
Rimonabant—Infection—Risedronate—osteoporosis	0.000209	0.00181	CcSEcCtD
Rimonabant—Gastrointestinal pain—Ibandronate—osteoporosis	0.000209	0.0018	CcSEcCtD
Rimonabant—Anxiety—Pamidronate—osteoporosis	0.000208	0.0018	CcSEcCtD
Rimonabant—Abdominal pain—Alendronate—osteoporosis	0.000207	0.00179	CcSEcCtD
Rimonabant—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000207	0.00179	CcSEcCtD
Rimonabant—Sinusitis—Estradiol—osteoporosis	0.000207	0.00179	CcSEcCtD
Rimonabant—Nervous system disorder—Risedronate—osteoporosis	0.000206	0.00178	CcSEcCtD
Rimonabant—Skin disorder—Risedronate—osteoporosis	0.000204	0.00177	CcSEcCtD
Rimonabant—Gastrointestinal pain—Calcitriol—osteoporosis	0.000204	0.00177	CcSEcCtD
Rimonabant—Abdominal pain—Raloxifene—osteoporosis	0.000204	0.00176	CcSEcCtD
Rimonabant—Abdominal pain—Ibandronate—osteoporosis	0.000202	0.00174	CcSEcCtD
Rimonabant—Infection—Pamidronate—osteoporosis	0.000199	0.00172	CcSEcCtD
Rimonabant—Abdominal pain—Calcitriol—osteoporosis	0.000198	0.00171	CcSEcCtD
Rimonabant—Hypoaesthesia—Estradiol—osteoporosis	0.000197	0.0017	CcSEcCtD
Rimonabant—Nervous system disorder—Pamidronate—osteoporosis	0.000196	0.0017	CcSEcCtD
Rimonabant—Vomiting—Etidronic acid—osteoporosis	0.000196	0.00169	CcSEcCtD
Rimonabant—Connective tissue disorder—Estradiol—osteoporosis	0.000195	0.00168	CcSEcCtD
Rimonabant—Rash—Etidronic acid—osteoporosis	0.000194	0.00168	CcSEcCtD
Rimonabant—Convulsion—Zoledronate—osteoporosis	0.000194	0.00168	CcSEcCtD
Rimonabant—Dermatitis—Etidronic acid—osteoporosis	0.000194	0.00168	CcSEcCtD
Rimonabant—Hyperhidrosis—Pamidronate—osteoporosis	0.000193	0.00167	CcSEcCtD
Rimonabant—Headache—Etidronic acid—osteoporosis	0.000193	0.00167	CcSEcCtD
Rimonabant—Asthenia—Estropipate—osteoporosis	0.000191	0.00165	CcSEcCtD
Rimonabant—Anorexia—Pamidronate—osteoporosis	0.000191	0.00165	CcSEcCtD
Rimonabant—Insomnia—Risedronate—osteoporosis	0.00019	0.00165	CcSEcCtD
Rimonabant—Anxiety—Zoledronate—osteoporosis	0.00019	0.00164	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000189	0.00164	CcSEcCtD
Rimonabant—Paraesthesia—Risedronate—osteoporosis	0.000189	0.00163	CcSEcCtD
Rimonabant—Pruritus—Estropipate—osteoporosis	0.000188	0.00163	CcSEcCtD
Rimonabant—Asthenia—Alendronate—osteoporosis	0.000188	0.00163	CcSEcCtD
Rimonabant—Convulsion—Conjugated Estrogens—osteoporosis	0.000187	0.00161	CcSEcCtD
Rimonabant—Dry mouth—Zoledronate—osteoporosis	0.000186	0.00161	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000186	0.00161	CcSEcCtD
Rimonabant—Fatigue—Ethinyl Estradiol—osteoporosis	0.000186	0.00161	CcSEcCtD
Rimonabant—Pruritus—Alendronate—osteoporosis	0.000186	0.0016	CcSEcCtD
Rimonabant—Asthenia—Ibandronate—osteoporosis	0.000183	0.00158	CcSEcCtD
Rimonabant—Anxiety—Conjugated Estrogens—osteoporosis	0.000183	0.00158	CcSEcCtD
Rimonabant—Nausea—Etidronic acid—osteoporosis	0.000183	0.00158	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000182	0.00158	CcSEcCtD
Rimonabant—Diarrhoea—Estropipate—osteoporosis	0.000182	0.00157	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Risedronate—osteoporosis	0.000182	0.00157	CcSEcCtD
Rimonabant—Infection—Zoledronate—osteoporosis	0.000182	0.00157	CcSEcCtD
Rimonabant—Fatigue—Risedronate—osteoporosis	0.000181	0.00157	CcSEcCtD
Rimonabant—Insomnia—Pamidronate—osteoporosis	0.000181	0.00156	CcSEcCtD
Rimonabant—Pruritus—Ibandronate—osteoporosis	0.000181	0.00156	CcSEcCtD
Rimonabant—Angiopathy—Estradiol—osteoporosis	0.00018	0.00155	CcSEcCtD
Rimonabant—Paraesthesia—Pamidronate—osteoporosis	0.00018	0.00155	CcSEcCtD
Rimonabant—Diarrhoea—Alendronate—osteoporosis	0.00018	0.00155	CcSEcCtD
Rimonabant—Asthenia—Calcitriol—osteoporosis	0.000179	0.00155	CcSEcCtD
Rimonabant—Nervous system disorder—Zoledronate—osteoporosis	0.000179	0.00155	CcSEcCtD
Rimonabant—Mediastinal disorder—Estradiol—osteoporosis	0.000179	0.00154	CcSEcCtD
Rimonabant—Skin disorder—Zoledronate—osteoporosis	0.000178	0.00153	CcSEcCtD
Rimonabant—Pruritus—Calcitriol—osteoporosis	0.000177	0.00153	CcSEcCtD
Rimonabant—Hyperhidrosis—Zoledronate—osteoporosis	0.000177	0.00153	CcSEcCtD
Rimonabant—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000177	0.00153	CcSEcCtD
Rimonabant—Diarrhoea—Raloxifene—osteoporosis	0.000177	0.00153	CcSEcCtD
Rimonabant—Dizziness—Estropipate—osteoporosis	0.000176	0.00152	CcSEcCtD
Rimonabant—Infection—Conjugated Estrogens—osteoporosis	0.000175	0.00151	CcSEcCtD
Rimonabant—Diarrhoea—Ibandronate—osteoporosis	0.000175	0.00151	CcSEcCtD
Rimonabant—Anorexia—Zoledronate—osteoporosis	0.000174	0.00151	CcSEcCtD
Rimonabant—Decreased appetite—Pamidronate—osteoporosis	0.000174	0.0015	CcSEcCtD
Rimonabant—Mental disorder—Estradiol—osteoporosis	0.000174	0.0015	CcSEcCtD
Rimonabant—Dizziness—Alendronate—osteoporosis	0.000173	0.0015	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000173	0.00149	CcSEcCtD
Rimonabant—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000173	0.00149	CcSEcCtD
Rimonabant—Malnutrition—Estradiol—osteoporosis	0.000173	0.00149	CcSEcCtD
Rimonabant—Fatigue—Pamidronate—osteoporosis	0.000173	0.00149	CcSEcCtD
Rimonabant—Gastrointestinal pain—Risedronate—osteoporosis	0.000172	0.00149	CcSEcCtD
Rimonabant—Diarrhoea—Calcitriol—osteoporosis	0.000171	0.00148	CcSEcCtD
Rimonabant—Skin disorder—Conjugated Estrogens—osteoporosis	0.000171	0.00148	CcSEcCtD
Rimonabant—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000171	0.00147	CcSEcCtD
Rimonabant—Dizziness—Raloxifene—osteoporosis	0.000171	0.00147	CcSEcCtD
Rimonabant—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00017	0.00147	CcSEcCtD
Rimonabant—Tension—Estradiol—osteoporosis	0.000169	0.00146	CcSEcCtD
Rimonabant—Vomiting—Estropipate—osteoporosis	0.000169	0.00146	CcSEcCtD
Rimonabant—Dizziness—Ibandronate—osteoporosis	0.000169	0.00146	CcSEcCtD
Rimonabant—Rash—Estropipate—osteoporosis	0.000168	0.00145	CcSEcCtD
Rimonabant—Dermatitis—Estropipate—osteoporosis	0.000168	0.00145	CcSEcCtD
Rimonabant—Anorexia—Conjugated Estrogens—osteoporosis	0.000168	0.00145	CcSEcCtD
Rimonabant—Nervousness—Estradiol—osteoporosis	0.000168	0.00145	CcSEcCtD
Rimonabant—Headache—Estropipate—osteoporosis	0.000167	0.00144	CcSEcCtD
Rimonabant—Vomiting—Alendronate—osteoporosis	0.000167	0.00144	CcSEcCtD
Rimonabant—Abdominal pain—Risedronate—osteoporosis	0.000166	0.00144	CcSEcCtD
Rimonabant—Muscle spasms—Estradiol—osteoporosis	0.000166	0.00143	CcSEcCtD
Rimonabant—Rash—Alendronate—osteoporosis	0.000165	0.00143	CcSEcCtD
Rimonabant—Insomnia—Zoledronate—osteoporosis	0.000165	0.00143	CcSEcCtD
Rimonabant—Dermatitis—Alendronate—osteoporosis	0.000165	0.00143	CcSEcCtD
Rimonabant—Headache—Alendronate—osteoporosis	0.000164	0.00142	CcSEcCtD
Rimonabant—Paraesthesia—Zoledronate—osteoporosis	0.000164	0.00142	CcSEcCtD
Rimonabant—Vomiting—Raloxifene—osteoporosis	0.000164	0.00142	CcSEcCtD
Rimonabant—Gastrointestinal pain—Pamidronate—osteoporosis	0.000164	0.00141	CcSEcCtD
Rimonabant—Rash—Raloxifene—osteoporosis	0.000163	0.00141	CcSEcCtD
Rimonabant—Dermatitis—Raloxifene—osteoporosis	0.000163	0.0014	CcSEcCtD
Rimonabant—Vomiting—Ibandronate—osteoporosis	0.000162	0.0014	CcSEcCtD
Rimonabant—Tremor—Estradiol—osteoporosis	0.000162	0.0014	CcSEcCtD
Rimonabant—Headache—Raloxifene—osteoporosis	0.000162	0.0014	CcSEcCtD
Rimonabant—Rash—Ibandronate—osteoporosis	0.000161	0.00139	CcSEcCtD
Rimonabant—Dermatitis—Ibandronate—osteoporosis	0.000161	0.00139	CcSEcCtD
Rimonabant—Headache—Ibandronate—osteoporosis	0.00016	0.00138	CcSEcCtD
Rimonabant—Insomnia—Conjugated Estrogens—osteoporosis	0.000159	0.00138	CcSEcCtD
Rimonabant—Vomiting—Calcitriol—osteoporosis	0.000159	0.00137	CcSEcCtD
Rimonabant—Decreased appetite—Zoledronate—osteoporosis	0.000159	0.00137	CcSEcCtD
Rimonabant—Nausea—Estropipate—osteoporosis	0.000158	0.00137	CcSEcCtD
Rimonabant—Abdominal pain—Pamidronate—osteoporosis	0.000158	0.00137	CcSEcCtD
Rimonabant—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000158	0.00137	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000158	0.00136	CcSEcCtD
Rimonabant—Rash—Calcitriol—osteoporosis	0.000158	0.00136	CcSEcCtD
Rimonabant—Fatigue—Zoledronate—osteoporosis	0.000158	0.00136	CcSEcCtD
Rimonabant—Dermatitis—Calcitriol—osteoporosis	0.000158	0.00136	CcSEcCtD
Rimonabant—Headache—Calcitriol—osteoporosis	0.000157	0.00135	CcSEcCtD
Rimonabant—Nausea—Alendronate—osteoporosis	0.000156	0.00135	CcSEcCtD
Rimonabant—Asthenia—Ethinyl Estradiol—osteoporosis	0.000155	0.00134	CcSEcCtD
Rimonabant—Nausea—Raloxifene—osteoporosis	0.000153	0.00132	CcSEcCtD
Rimonabant—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000153	0.00132	CcSEcCtD
Rimonabant—Pruritus—Ethinyl Estradiol—osteoporosis	0.000153	0.00132	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000152	0.00131	CcSEcCtD
Rimonabant—Fatigue—Conjugated Estrogens—osteoporosis	0.000152	0.00131	CcSEcCtD
Rimonabant—Nausea—Ibandronate—osteoporosis	0.000152	0.00131	CcSEcCtD
Rimonabant—Asthenia—Risedronate—osteoporosis	0.000151	0.00131	CcSEcCtD
Rimonabant—Gastrointestinal pain—Zoledronate—osteoporosis	0.000149	0.00129	CcSEcCtD
Rimonabant—Pruritus—Risedronate—osteoporosis	0.000149	0.00129	CcSEcCtD
Rimonabant—Nausea—Calcitriol—osteoporosis	0.000149	0.00128	CcSEcCtD
Rimonabant—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000148	0.00128	CcSEcCtD
Rimonabant—Anxiety—Estradiol—osteoporosis	0.000146	0.00127	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000146	0.00126	CcSEcCtD
Rimonabant—Abdominal pain—Zoledronate—osteoporosis	0.000144	0.00125	CcSEcCtD
Rimonabant—Diarrhoea—Risedronate—osteoporosis	0.000144	0.00124	CcSEcCtD
Rimonabant—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000144	0.00124	CcSEcCtD
Rimonabant—Dry mouth—Estradiol—osteoporosis	0.000144	0.00124	CcSEcCtD
Rimonabant—Asthenia—Pamidronate—osteoporosis	0.000144	0.00124	CcSEcCtD
Rimonabant—Dizziness—Ethinyl Estradiol—osteoporosis	0.000143	0.00123	CcSEcCtD
Rimonabant—Pruritus—Pamidronate—osteoporosis	0.000142	0.00122	CcSEcCtD
Rimonabant—Infection—Estradiol—osteoporosis	0.00014	0.00121	CcSEcCtD
Rimonabant—Dizziness—Risedronate—osteoporosis	0.000139	0.0012	CcSEcCtD
Rimonabant—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000139	0.0012	CcSEcCtD
Rimonabant—Nervous system disorder—Estradiol—osteoporosis	0.000138	0.00119	CcSEcCtD
Rimonabant—Vomiting—Ethinyl Estradiol—osteoporosis	0.000137	0.00119	CcSEcCtD
Rimonabant—Diarrhoea—Pamidronate—osteoporosis	0.000137	0.00118	CcSEcCtD
Rimonabant—Skin disorder—Estradiol—osteoporosis	0.000137	0.00118	CcSEcCtD
Rimonabant—Hyperhidrosis—Estradiol—osteoporosis	0.000136	0.00118	CcSEcCtD
Rimonabant—Rash—Ethinyl Estradiol—osteoporosis	0.000136	0.00118	CcSEcCtD
Rimonabant—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000136	0.00118	CcSEcCtD
Rimonabant—Headache—Ethinyl Estradiol—osteoporosis	0.000135	0.00117	CcSEcCtD
Rimonabant—Vomiting—Risedronate—osteoporosis	0.000134	0.00116	CcSEcCtD
Rimonabant—Rash—Risedronate—osteoporosis	0.000133	0.00115	CcSEcCtD
Rimonabant—Dermatitis—Risedronate—osteoporosis	0.000133	0.00115	CcSEcCtD
Rimonabant—Dizziness—Pamidronate—osteoporosis	0.000132	0.00114	CcSEcCtD
Rimonabant—Headache—Risedronate—osteoporosis	0.000132	0.00114	CcSEcCtD
Rimonabant—Asthenia—Zoledronate—osteoporosis	0.000131	0.00113	CcSEcCtD
Rimonabant—Pruritus—Zoledronate—osteoporosis	0.000129	0.00112	CcSEcCtD
Rimonabant—Nausea—Ethinyl Estradiol—osteoporosis	0.000128	0.00111	CcSEcCtD
Rimonabant—Insomnia—Estradiol—osteoporosis	0.000127	0.0011	CcSEcCtD
Rimonabant—Vomiting—Pamidronate—osteoporosis	0.000127	0.0011	CcSEcCtD
Rimonabant—Paraesthesia—Estradiol—osteoporosis	0.000126	0.00109	CcSEcCtD
Rimonabant—Asthenia—Conjugated Estrogens—osteoporosis	0.000126	0.00109	CcSEcCtD
Rimonabant—Rash—Pamidronate—osteoporosis	0.000126	0.00109	CcSEcCtD
Rimonabant—Dermatitis—Pamidronate—osteoporosis	0.000126	0.00109	CcSEcCtD
Rimonabant—Headache—Pamidronate—osteoporosis	0.000125	0.00108	CcSEcCtD
Rimonabant—Diarrhoea—Zoledronate—osteoporosis	0.000125	0.00108	CcSEcCtD
Rimonabant—Nausea—Risedronate—osteoporosis	0.000125	0.00108	CcSEcCtD
Rimonabant—Pruritus—Conjugated Estrogens—osteoporosis	0.000125	0.00108	CcSEcCtD
Rimonabant—Decreased appetite—Estradiol—osteoporosis	0.000122	0.00106	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Estradiol—osteoporosis	0.000122	0.00105	CcSEcCtD
Rimonabant—Fatigue—Estradiol—osteoporosis	0.000121	0.00105	CcSEcCtD
Rimonabant—Dizziness—Zoledronate—osteoporosis	0.000121	0.00104	CcSEcCtD
Rimonabant—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00012	0.00104	CcSEcCtD
Rimonabant—Nausea—Pamidronate—osteoporosis	0.000119	0.00103	CcSEcCtD
Rimonabant—Dizziness—Conjugated Estrogens—osteoporosis	0.000116	0.00101	CcSEcCtD
Rimonabant—Vomiting—Zoledronate—osteoporosis	0.000116	0.001	CcSEcCtD
Rimonabant—Rash—Zoledronate—osteoporosis	0.000115	0.000996	CcSEcCtD
Rimonabant—Gastrointestinal pain—Estradiol—osteoporosis	0.000115	0.000995	CcSEcCtD
Rimonabant—Dermatitis—Zoledronate—osteoporosis	0.000115	0.000995	CcSEcCtD
Rimonabant—Headache—Zoledronate—osteoporosis	0.000115	0.000989	CcSEcCtD
Rimonabant—Vomiting—Conjugated Estrogens—osteoporosis	0.000112	0.000967	CcSEcCtD
Rimonabant—Abdominal pain—Estradiol—osteoporosis	0.000111	0.000962	CcSEcCtD
Rimonabant—Rash—Conjugated Estrogens—osteoporosis	0.000111	0.000959	CcSEcCtD
Rimonabant—Dermatitis—Conjugated Estrogens—osteoporosis	0.000111	0.000958	CcSEcCtD
Rimonabant—Headache—Conjugated Estrogens—osteoporosis	0.00011	0.000953	CcSEcCtD
Rimonabant—Nausea—Zoledronate—osteoporosis	0.000109	0.000938	CcSEcCtD
Rimonabant—Nausea—Conjugated Estrogens—osteoporosis	0.000105	0.000903	CcSEcCtD
Rimonabant—Asthenia—Estradiol—osteoporosis	0.000101	0.000873	CcSEcCtD
Rimonabant—Pruritus—Estradiol—osteoporosis	9.97e-05	0.000861	CcSEcCtD
Rimonabant—Diarrhoea—Estradiol—osteoporosis	9.64e-05	0.000833	CcSEcCtD
Rimonabant—CNR2—Signaling Pathways—LRP6—osteoporosis	9.6e-05	0.00343	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—PTHLH—osteoporosis	9.54e-05	0.00341	CbGpPWpGaD
Rimonabant—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	9.4e-05	0.00336	CbGpPWpGaD
Rimonabant—Dizziness—Estradiol—osteoporosis	9.31e-05	0.000805	CcSEcCtD
Rimonabant—CNR2—GPCR downstream signaling—CALCA—osteoporosis	9.25e-05	0.0033	CbGpPWpGaD
Rimonabant—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	9.05e-05	0.00323	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PTH—osteoporosis	9.04e-05	0.00323	CbGpPWpGaD
Rimonabant—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	8.97e-05	0.0032	CbGpPWpGaD
Rimonabant—Vomiting—Estradiol—osteoporosis	8.96e-05	0.000774	CcSEcCtD
Rimonabant—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	8.9e-05	0.00318	CbGpPWpGaD
Rimonabant—Rash—Estradiol—osteoporosis	8.88e-05	0.000767	CcSEcCtD
Rimonabant—Dermatitis—Estradiol—osteoporosis	8.87e-05	0.000767	CcSEcCtD
Rimonabant—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	8.86e-05	0.00316	CbGpPWpGaD
Rimonabant—CNR1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	8.83e-05	0.00315	CbGpPWpGaD
Rimonabant—Headache—Estradiol—osteoporosis	8.82e-05	0.000763	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—CNR2—osteoporosis	8.81e-05	0.00314	CbGpPWpGaD
Rimonabant—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	8.78e-05	0.00313	CbGpPWpGaD
Rimonabant—CNR2—GPCR ligand binding—POMC—osteoporosis	8.56e-05	0.00306	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—CALCA—osteoporosis	8.4e-05	0.003	CbGpPWpGaD
Rimonabant—CYP2C9—Arachidonic acid metabolism—GPX1—osteoporosis	8.38e-05	0.00299	CbGpPWpGaD
Rimonabant—Nausea—Estradiol—osteoporosis	8.37e-05	0.000723	CcSEcCtD
Rimonabant—CNR1—Signaling by GPCR—WNT1—osteoporosis	8.28e-05	0.00296	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—PTHLH—osteoporosis	8.25e-05	0.00294	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TLN1—osteoporosis	8.11e-05	0.0029	CbGpPWpGaD
Rimonabant—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	8.08e-05	0.00288	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MGLL—osteoporosis	8.07e-05	0.00288	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—LRP5—osteoporosis	7.88e-05	0.00281	CbGpPWpGaD
Rimonabant—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	7.6e-05	0.00271	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—LRP6—osteoporosis	7.54e-05	0.00269	CbGpPWpGaD
Rimonabant—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	7.5e-05	0.00268	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—PTHLH—osteoporosis	7.49e-05	0.00267	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—CYP27A1—osteoporosis	7.36e-05	0.00263	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	7.29e-05	0.0026	CbGpPWpGaD
Rimonabant—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	7.27e-05	0.0026	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—CALCA—osteoporosis	7.26e-05	0.00259	CbGpPWpGaD
Rimonabant—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	7.26e-05	0.00259	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—CYP27A1—osteoporosis	7.26e-05	0.00259	CbGpPWpGaD
Rimonabant—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	7.21e-05	0.00257	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	7.19e-05	0.00257	CbGpPWpGaD
Rimonabant—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	7.16e-05	0.00256	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—P4HB—osteoporosis	6.99e-05	0.0025	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PTH—osteoporosis	6.8e-05	0.00243	CbGpPWpGaD
Rimonabant—CNR1—GPCR ligand binding—POMC—osteoporosis	6.72e-05	0.0024	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—RAP1A—osteoporosis	6.69e-05	0.00239	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—CALCA—osteoporosis	6.59e-05	0.00235	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—ADCY5—osteoporosis	6.58e-05	0.00235	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—NFATC1—osteoporosis	6.52e-05	0.00233	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—DKK1—osteoporosis	6.47e-05	0.00231	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TLN1—osteoporosis	6.36e-05	0.00227	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	6.28e-05	0.00224	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—WNT1—osteoporosis	6.23e-05	0.00223	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	6.23e-05	0.00223	CbGpPWpGaD
Rimonabant—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	6.16e-05	0.0022	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	6.15e-05	0.00219	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—FGA—osteoporosis	6.06e-05	0.00216	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—ADCY5—osteoporosis	5.98e-05	0.00213	CbGpPWpGaD
Rimonabant—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	5.87e-05	0.00209	CbGpPWpGaD
Rimonabant—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	5.79e-05	0.00207	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PTHLH—osteoporosis	5.64e-05	0.00201	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—BMP2—osteoporosis	5.64e-05	0.00201	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—FGB—osteoporosis	5.52e-05	0.00197	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—P4HB—osteoporosis	5.49e-05	0.00196	CbGpPWpGaD
Rimonabant—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.39e-05	0.00193	CbGpPWpGaD
Rimonabant—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.35e-05	0.00191	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTH—osteoporosis	5.34e-05	0.00191	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PSMA2—osteoporosis	5.33e-05	0.0019	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—PSMA5—osteoporosis	5.33e-05	0.0019	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—RAP1A—osteoporosis	5.25e-05	0.00187	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CNR2—osteoporosis	5.2e-05	0.00186	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—ADCY5—osteoporosis	5.16e-05	0.00184	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—NFATC1—osteoporosis	5.12e-05	0.00183	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—DKK1—osteoporosis	5.08e-05	0.00181	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—CALCA—osteoporosis	4.96e-05	0.00177	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—WNT1—osteoporosis	4.89e-05	0.00175	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	4.88e-05	0.00174	CbGpPWpGaD
Rimonabant—CNR2—GPCR downstream signaling—POMC—osteoporosis	4.84e-05	0.00173	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	4.81e-05	0.00172	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—FGA—osteoporosis	4.76e-05	0.0017	CbGpPWpGaD
Rimonabant—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.76e-05	0.0017	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	4.74e-05	0.00169	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—ADCY5—osteoporosis	4.69e-05	0.00167	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	4.62e-05	0.00165	CbGpPWpGaD
Rimonabant—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	4.57e-05	0.00163	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—KL—osteoporosis	4.51e-05	0.00161	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PTHLH—osteoporosis	4.42e-05	0.00158	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—BMP2—osteoporosis	4.42e-05	0.00158	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—POMC—osteoporosis	4.4e-05	0.00157	CbGpPWpGaD
Rimonabant—CYP2D6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.37e-05	0.00156	CbGpPWpGaD
Rimonabant—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.33e-05	0.00155	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—FGB—osteoporosis	4.33e-05	0.00155	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL6R—osteoporosis	4.29e-05	0.00153	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	4.19e-05	0.0015	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PSMA5—osteoporosis	4.18e-05	0.00149	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—PSMA2—osteoporosis	4.18e-05	0.00149	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	4.17e-05	0.00149	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.95e-05	0.00141	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—CALCA—osteoporosis	3.89e-05	0.00139	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—CYP19A1—osteoporosis	3.86e-05	0.00138	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	3.83e-05	0.00137	CbGpPWpGaD
Rimonabant—CYP2D6—Metapathway biotransformation—CYP19A1—osteoporosis	3.81e-05	0.00136	CbGpPWpGaD
Rimonabant—CNR1—GPCR downstream signaling—POMC—osteoporosis	3.8e-05	0.00136	CbGpPWpGaD
Rimonabant—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	3.78e-05	0.00135	CbGpPWpGaD
Rimonabant—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.7e-05	0.00132	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.59e-05	0.00128	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—KL—osteoporosis	3.54e-05	0.00126	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ADCY5—osteoporosis	3.53e-05	0.00126	CbGpPWpGaD
Rimonabant—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.53e-05	0.00126	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	3.5e-05	0.00125	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—POMC—osteoporosis	3.45e-05	0.00123	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—SPP1—osteoporosis	3.42e-05	0.00122	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL6R—osteoporosis	3.36e-05	0.0012	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	3.27e-05	0.00117	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	3.27e-05	0.00117	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	3.26e-05	0.00116	CbGpPWpGaD
Rimonabant—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	3.23e-05	0.00115	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IRS2—osteoporosis	3.09e-05	0.0011	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	3.07e-05	0.0011	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	3.04e-05	0.00109	CbGpPWpGaD
Rimonabant—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	3.04e-05	0.00109	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—LEP—osteoporosis	3.02e-05	0.00108	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.99e-05	0.00107	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—ESR1—osteoporosis	2.89e-05	0.00103	CbGpPWpGaD
Rimonabant—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.86e-05	0.00102	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.8e-05	0.001	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ADCY5—osteoporosis	2.77e-05	0.000989	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IRS1—osteoporosis	2.7e-05	0.000963	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—SPP1—osteoporosis	2.68e-05	0.000957	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—POMC—osteoporosis	2.6e-05	0.000927	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL6R—osteoporosis	2.53e-05	0.000904	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	2.53e-05	0.000902	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IGF1—osteoporosis	2.5e-05	0.000892	CbGpPWpGaD
Rimonabant—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	2.49e-05	0.00089	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IRS2—osteoporosis	2.42e-05	0.000865	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.39e-05	0.000854	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.38e-05	0.00085	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—LEP—osteoporosis	2.37e-05	0.000847	CbGpPWpGaD
Rimonabant—CYP2D6—Biological oxidations—POMC—osteoporosis	2.32e-05	0.000829	CbGpPWpGaD
Rimonabant—CYP2C9—Biological oxidations—POMC—osteoporosis	2.3e-05	0.000822	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—ESR1—osteoporosis	2.26e-05	0.000808	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—FDPS—osteoporosis	2.19e-05	0.000782	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PKM—osteoporosis	2.19e-05	0.000782	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—FDPS—osteoporosis	2.17e-05	0.000775	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PKM—osteoporosis	2.17e-05	0.000775	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IRS1—osteoporosis	2.12e-05	0.000755	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PGLS—osteoporosis	2.08e-05	0.000741	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GPD2—osteoporosis	2.08e-05	0.000741	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PGLS—osteoporosis	2.06e-05	0.000735	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GPD2—osteoporosis	2.06e-05	0.000735	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—POMC—osteoporosis	2.04e-05	0.000727	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.03e-05	0.000726	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL6R—osteoporosis	1.99e-05	0.00071	CbGpPWpGaD
Rimonabant—CYP1A2—Biological oxidations—POMC—osteoporosis	1.97e-05	0.000702	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IGF1—osteoporosis	1.96e-05	0.0007	CbGpPWpGaD
Rimonabant—CNR2—Signaling by GPCR—IL6—osteoporosis	1.91e-05	0.000682	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ATIC—osteoporosis	1.9e-05	0.000678	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PNP—osteoporosis	1.9e-05	0.000678	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PNP—osteoporosis	1.88e-05	0.000672	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ATIC—osteoporosis	1.88e-05	0.000672	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PKM—osteoporosis	1.86e-05	0.000663	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—FDPS—osteoporosis	1.86e-05	0.000663	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GPD2—osteoporosis	1.76e-05	0.000628	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PGLS—osteoporosis	1.76e-05	0.000628	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CA2—osteoporosis	1.61e-05	0.000577	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—OXCT1—osteoporosis	1.61e-05	0.000577	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PNP—osteoporosis	1.61e-05	0.000574	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ATIC—osteoporosis	1.61e-05	0.000574	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—OXCT1—osteoporosis	1.6e-05	0.000572	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CA2—osteoporosis	1.6e-05	0.000572	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MGLL—osteoporosis	1.57e-05	0.000562	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MGLL—osteoporosis	1.56e-05	0.000557	CbGpPWpGaD
Rimonabant—CYP3A4—Biological oxidations—POMC—osteoporosis	1.52e-05	0.000542	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—MYC—osteoporosis	1.5e-05	0.000536	CbGpPWpGaD
Rimonabant—CNR1—Signaling by GPCR—IL6—osteoporosis	1.5e-05	0.000535	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—TGFB1—osteoporosis	1.5e-05	0.000535	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.47e-05	0.000525	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PKM—osteoporosis	1.43e-05	0.000511	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—FDPS—osteoporosis	1.43e-05	0.000511	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—OXCT1—osteoporosis	1.37e-05	0.000488	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CA2—osteoporosis	1.37e-05	0.000488	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GPD2—osteoporosis	1.36e-05	0.000485	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PGLS—osteoporosis	1.36e-05	0.000485	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—IDH2—osteoporosis	1.34e-05	0.000478	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MGLL—osteoporosis	1.33e-05	0.000476	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—IDH2—osteoporosis	1.33e-05	0.000474	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.26e-05	0.000449	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.26e-05	0.000449	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.25e-05	0.000445	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PNP—osteoporosis	1.24e-05	0.000443	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ATIC—osteoporosis	1.24e-05	0.000443	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ACP5—osteoporosis	1.22e-05	0.000437	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ACP5—osteoporosis	1.21e-05	0.000433	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.2e-05	0.000428	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—MYC—osteoporosis	1.18e-05	0.000421	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—TGFB1—osteoporosis	1.17e-05	0.000419	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—TPI1—osteoporosis	1.14e-05	0.000406	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—IDH2—osteoporosis	1.13e-05	0.000405	CbGpPWpGaD
Rimonabant—CNR2—Signaling Pathways—IL6—osteoporosis	1.13e-05	0.000403	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—TPI1—osteoporosis	1.13e-05	0.000403	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—P4HB—osteoporosis	1.07e-05	0.000382	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP27A1—osteoporosis	1.07e-05	0.000381	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—P4HB—osteoporosis	1.06e-05	0.000379	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CA2—osteoporosis	1.06e-05	0.000377	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—OXCT1—osteoporosis	1.06e-05	0.000377	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GAPDH—osteoporosis	1.05e-05	0.000375	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GAPDH—osteoporosis	1.04e-05	0.000372	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ACP5—osteoporosis	1.04e-05	0.00037	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MGLL—osteoporosis	1.03e-05	0.000367	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.02e-05	0.000365	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—RAP1A—osteoporosis	1.02e-05	0.000365	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—RAP1A—osteoporosis	1.01e-05	0.000362	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—TPI1—osteoporosis	9.64e-06	0.000344	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—P4HB—osteoporosis	9.06e-06	0.000324	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GAPDH—osteoporosis	8.9e-06	0.000318	CbGpPWpGaD
Rimonabant—CNR1—Signaling Pathways—IL6—osteoporosis	8.85e-06	0.000316	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.84e-06	0.000316	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—IDH2—osteoporosis	8.75e-06	0.000312	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—RAP1A—osteoporosis	8.66e-06	0.000309	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ENO1—osteoporosis	8.27e-06	0.000295	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP27A1—osteoporosis	8.23e-06	0.000294	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ENO1—osteoporosis	8.2e-06	0.000293	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PSMA5—osteoporosis	8.15e-06	0.000291	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—PSMA2—osteoporosis	8.15e-06	0.000291	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PSMA2—osteoporosis	8.08e-06	0.000288	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—PSMA5—osteoporosis	8.08e-06	0.000288	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ACP5—osteoporosis	8e-06	0.000286	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.56e-06	0.00027	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—TPI1—osteoporosis	7.44e-06	0.000266	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ENO1—osteoporosis	7e-06	0.00025	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—P4HB—osteoporosis	6.99e-06	0.00025	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PSMA2—osteoporosis	6.9e-06	0.000246	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—PSMA5—osteoporosis	6.9e-06	0.000246	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GAPDH—osteoporosis	6.86e-06	0.000245	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—RAP1A—osteoporosis	6.69e-06	0.000239	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—CYP19A1—osteoporosis	6.61e-06	0.000236	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—CYP19A1—osteoporosis	6.55e-06	0.000234	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—CYP19A1—osteoporosis	5.6e-06	0.0002	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ENO1—osteoporosis	5.4e-06	0.000193	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—ADCY5—osteoporosis	5.4e-06	0.000193	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—GPX1—osteoporosis	5.38e-06	0.000192	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—ADCY5—osteoporosis	5.35e-06	0.000191	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—GPX1—osteoporosis	5.33e-06	0.00019	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PSMA2—osteoporosis	5.33e-06	0.00019	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—PSMA5—osteoporosis	5.33e-06	0.00019	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—MTHFR—osteoporosis	4.97e-06	0.000177	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—MTHFR—osteoporosis	4.92e-06	0.000176	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—ADCY5—osteoporosis	4.57e-06	0.000163	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—GPX1—osteoporosis	4.56e-06	0.000163	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—CYP19A1—osteoporosis	4.32e-06	0.000154	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—MTHFR—osteoporosis	4.21e-06	0.00015	CbGpPWpGaD
Rimonabant—CYP2D6—Metabolism—POMC—osteoporosis	3.97e-06	0.000142	CbGpPWpGaD
Rimonabant—CYP2C9—Metabolism—POMC—osteoporosis	3.94e-06	0.000141	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—ADCY5—osteoporosis	3.53e-06	0.000126	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—GPX1—osteoporosis	3.52e-06	0.000126	CbGpPWpGaD
Rimonabant—CYP1A2—Metabolism—POMC—osteoporosis	3.36e-06	0.00012	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—MTHFR—osteoporosis	3.25e-06	0.000116	CbGpPWpGaD
Rimonabant—CYP3A4—Metabolism—POMC—osteoporosis	2.6e-06	9.27e-05	CbGpPWpGaD
